Global Competent Cells Market 2020 by Company, Regions, Type and Application, Forecast to 2025
Summary
Market Overview
The global Competent Cells market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.1% in the forecast period of 2020 to 2025 and will expected to reach USD 2423.3 million by 2025, from USD 1711 million in 2019.
The Competent Cells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Competent Cells market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Competent Cells market has been segmented into Chemically Competent Cells, Electrocompetent Cells, etc.
By Application, Competent Cells has been segmented into Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, High-Throughput Cloning, Protein Expression, Mutagenesis, Single-Stranded DNA Production, Bacmid creation, Cre-lox recombination (PIR1/PIR2), etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Competent Cells market presented in the report. This section sheds light on the sales growth of different regional and country-level Competent Cells markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Competent Cells market.
The report offers in-depth assessment of the growth and other aspects of the Competent Cells market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Competent Cells markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Competent Cells Market Share Analysis
Competent Cells competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Competent Cells sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Competent Cells sales, revenue and market share for each player covered in this report.
The major players covered in Competent Cells are: Merck KGaA, Yeastern Biotech, Takara Bio, Thermo Fisher Scientific, GeneScript Corporation, Agilent Technologies, QIAGEN N.V., Beijing TransGen Biotech, Promega Corporation, New England Biolabs, Bioline, Cell Applications, OriGene Technologies, Scarab Genomics, Delphi Genetics, Bio-Rad Laboratories, Lucigen, BioDynamics Laboratory, IBA GmBH, Zymo Research, GCC Biotech, SMOBIO Technology, Edge BioSystems, etc. Among other players domestic and global, Competent Cells market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Table of Contents
1 Competent Cells Market Overview
1.1 Product Overview and Scope of Competent Cells
1.2 Classification of Competent Cells by Type
1.2.1 Global Competent Cells Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Competent Cells Revenue Market Share by Type in 2019
1.2.3 Chemically Competent Cells
1.2.4 Electrocompetent Cells
1.3 Global Competent Cells Market by Application
1.3.1 Overview: Global Competent Cells Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Subcloning & Routine Cloning
1.3.3 Phage Display Library Construction
1.3.4 Toxic/Unstable DNA Cloning
1.3.5 High-Throughput Cloning
1.3.6 Protein Expression
1.3.7 Mutagenesis
1.3.8 Single-Stranded DNA Production
1.3.9 Bacmid creation
1.3.10 Cre-lox recombination (PIR1/PIR2)
1.4 Global Competent Cells Market by Regions
1.4.1 Global Competent Cells Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Competent Cells (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Competent Cells Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Competent Cells Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Competent Cells Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Competent Cells Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Competent Cells Status and Prospect (2015-2025)
2 Company Profiles
2.1 Merck KGaA
2.1.1 Merck KGaA Details
2.1.2 Merck KGaA Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck KGaA SWOT Analysis
2.1.4 Merck KGaA Product and Services
2.1.5 Merck KGaA Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.2 Yeastern Biotech
2.2.1 Yeastern Biotech Details
2.2.2 Yeastern Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Yeastern Biotech SWOT Analysis
2.2.4 Yeastern Biotech Product and Services
2.2.5 Yeastern Biotech Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.3 Takara Bio
2.3.1 Takara Bio Details
2.3.2 Takara Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Takara Bio SWOT Analysis
2.3.4 Takara Bio Product and Services
2.3.5 Takara Bio Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Thermo Fisher Scientific SWOT Analysis
2.4.4 Thermo Fisher Scientific Product and Services
2.4.5 Thermo Fisher Scientific Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.5 GeneScript Corporation
2.5.1 GeneScript Corporation Details
2.5.2 GeneScript Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GeneScript Corporation SWOT Analysis
2.5.4 GeneScript Corporation Product and Services
2.5.5 GeneScript Corporation Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.6 Agilent Technologies
2.6.1 Agilent Technologies Details
2.6.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Agilent Technologies SWOT Analysis
2.6.4 Agilent Technologies Product and Services
2.6.5 Agilent Technologies Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.7 QIAGEN N.V.
2.7.1 QIAGEN N.V. Details
2.7.2 QIAGEN N.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 QIAGEN N.V. SWOT Analysis
2.7.4 QIAGEN N.V. Product and Services
2.7.5 QIAGEN N.V. Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.8 Beijing TransGen Biotech
2.8.1 Beijing TransGen Biotech Details
2.8.2 Beijing TransGen Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Beijing TransGen Biotech SWOT Analysis
2.8.4 Beijing TransGen Biotech Product and Services
2.8.5 Beijing TransGen Biotech Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.9 Promega Corporation
2.9.1 Promega Corporation Details
2.9.2 Promega Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Promega Corporation SWOT Analysis
2.9.4 Promega Corporation Product and Services
2.9.5 Promega Corporation Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.10 New England Biolabs
2.10.1 New England Biolabs Details
2.10.2 New England Biolabs Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 New England Biolabs SWOT Analysis
2.10.4 New England Biolabs Product and Services
2.10.5 New England Biolabs Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.11 Bioline
2.11.1 Bioline Details
2.11.2 Bioline Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Bioline SWOT Analysis
2.11.4 Bioline Product and Services
2.11.5 Bioline Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.12 Cell Applications
2.12.1 Cell Applications Details
2.12.2 Cell Applications Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Cell Applications SWOT Analysis
2.12.4 Cell Applications Product and Services
2.12.5 Cell Applications Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.13 OriGene Technologies
2.13.1 OriGene Technologies Details
2.13.2 OriGene Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 OriGene Technologies SWOT Analysis
2.13.4 OriGene Technologies Product and Services
2.13.5 OriGene Technologies Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.14 Scarab Genomics
2.14.1 Scarab Genomics Details
2.14.2 Scarab Genomics Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Scarab Genomics SWOT Analysis
2.14.4 Scarab Genomics Product and Services
2.14.5 Scarab Genomics Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.15 Delphi Genetics
2.15.1 Delphi Genetics Details
2.15.2 Delphi Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Delphi Genetics SWOT Analysis
2.15.4 Delphi Genetics Product and Services
2.15.5 Delphi Genetics Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.16 Bio-Rad Laboratories
2.16.1 Bio-Rad Laboratories Details
2.16.2 Bio-Rad Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Bio-Rad Laboratories SWOT Analysis
2.16.4 Bio-Rad Laboratories Product and Services
2.16.5 Bio-Rad Laboratories Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.17 Lucigen
2.17.1 Lucigen Details
2.17.2 Lucigen Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Lucigen SWOT Analysis
2.17.4 Lucigen Product and Services
2.17.5 Lucigen Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.18 BioDynamics Laboratory
2.18.1 BioDynamics Laboratory Details
2.18.2 BioDynamics Laboratory Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 BioDynamics Laboratory SWOT Analysis
2.18.4 BioDynamics Laboratory Product and Services
2.18.3 BioDynamics Laboratory Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.19 IBA GmBH
2.19.1 IBA GmBH Details
2.19.2 IBA GmBH Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 IBA GmBH SWOT Analysis
2.19.4 IBA GmBH Product and Services
2.19.5 IBA GmBH Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.20 Zymo Research
2.20.1 Zymo Research Details
2.20.2 Zymo Research Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Zymo Research SWOT Analysis
2.20.4 Zymo Research Product and Services
2.20.5 Zymo Research Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.21 GCC Biotech
2.21.1 GCC Biotech Details
2.21.2 GCC Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 GCC Biotech SWOT Analysis
2.21.4 GCC Biotech Product and Services
2.21.5 GCC Biotech Competent Cells Revenue, Gross Margin and Market Share (2018-2019)
2.22 SMOBIO Technology
2.23 Edge BioSystems
3 Market Competition, by Players
3.1 Global Competent Cells Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Competent Cells Players Market Share
3.2.2 Top 10 Competent Cells Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Competent Cells Revenue and Market Share by Regions
4.2 North America Competent Cells Revenue and Growth Rate (2015-2020)
4.3 Europe Competent Cells Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Competent Cells Revenue and Growth Rate (2015-2020)
4.5 South America Competent Cells Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Competent Cells Revenue and Growth Rate (2015-2020)
5 North America Competent Cells Revenue by Countries
5.1 North America Competent Cells Revenue by Countries (2015-2020)
5.2 USA Competent Cells Revenue and Growth Rate (2015-2020)
5.3 Canada Competent Cells Revenue and Growth Rate (2015-2020)
5.4 Mexico Competent Cells Revenue and Growth Rate (2015-2020)
6 Europe Competent Cells Revenue by Countries
6.1 Europe Competent Cells Revenue by Countries (2015-2020)
6.2 Germany Competent Cells Revenue and Growth Rate (2015-2020)
6.3 UK Competent Cells Revenue and Growth Rate (2015-2020)
6.4 France Competent Cells Revenue and Growth Rate (2015-2020)
6.5 Russia Competent Cells Revenue and Growth Rate (2015-2020)
6.6 Italy Competent Cells Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Competent Cells Revenue by Countries
7.1 Asia-Pacific Competent Cells Revenue by Countries (2015-2020)
7.2 China Competent Cells Revenue and Growth Rate (2015-2020)
7.3 Japan Competent Cells Revenue and Growth Rate (2015-2020)
7.4 Korea Competent Cells Revenue and Growth Rate (2015-2020)
7.5 India Competent Cells Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Competent Cells Revenue and Growth Rate (2015-2020)
8 South America Competent Cells Revenue by Countries
8.1 South America Competent Cells Revenue by Countries (2015-2020)
8.2 Brazil Competent Cells Revenue and Growth Rate (2015-2020)
8.3 Argentina Competent Cells Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Competent Cells by Countries
9.1 Middle East & Africa Competent Cells Revenue by Countries (2015-2020)
9.2 Saudi Arabia Competent Cells Revenue and Growth Rate (2015-2020)
9.3 UAE Competent Cells Revenue and Growth Rate (2015-2020)
9.4 Egypt Competent Cells Revenue and Growth Rate (2015-2020)
9.5 South Africa Competent Cells Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Competent Cells Revenue and Market Share by Type (2015-2020)
10.2 Global Competent Cells Market Forecast by Type (2019-2024)
10.3 Chemically Competent Cells Revenue Growth Rate (2015-2025)
10.4 Electrocompetent Cells Revenue Growth Rate (2015-2025)
11 Global Competent Cells Market Segment by Application
11.1 Global Competent Cells Revenue Market Share by Application (2015-2020)
11.2 Competent Cells Market Forecast by Application (2019-2024)
11.3 Subcloning & Routine Cloning Revenue Growth (2015-2020)
11.4 Phage Display Library Construction Revenue Growth (2015-2020)
11.5 Toxic/Unstable DNA Cloning Revenue Growth (2015-2020)
11.6 High-Throughput Cloning Revenue Growth (2015-2020)
11.7 Protein Expression Revenue Growth (2015-2020)
11.8 Mutagenesis Revenue Growth (2015-2020)
11.9 Single-Stranded DNA Production Revenue Growth (2015-2020)
11.10 Bacmid creation Revenue Growth (2015-2020)
11.11 Cre-lox recombination (PIR1/PIR2) Revenue Growth (2015-2020)
12 Global Competent Cells Market Size Forecast (2021-2025)
12.1 Global Competent Cells Market Size Forecast (2021-2025)
12.2 Global Competent Cells Market Forecast by Regions (2021-2025)
12.3 North America Competent Cells Revenue Market Forecast (2021-2025)
12.4 Europe Competent Cells Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Competent Cells Revenue Market Forecast (2021-2025)
12.6 South America Competent Cells Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Competent Cells Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global Competent Cells Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Competent Cells by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Competent Cells Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Competent Cells Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Merck KGaA Corporate Information, Location and Competitors
Table 6. Merck KGaA Competent Cells Major Business
Table 7. Merck KGaA Competent Cells Total Revenue (USD Million) (2017-2018)
Table 8. Merck KGaA SWOT Analysis
Table 9. Merck KGaA Competent Cells Product and Solutions
Table 10. Merck KGaA Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Yeastern Biotech Corporate Information, Location and Competitors
Table 12. Yeastern Biotech Competent Cells Major Business
Table 13. Yeastern Biotech Competent Cells Total Revenue (USD Million) (2018-2019)
Table 14. Yeastern Biotech SWOT Analysis
Table 15. Yeastern Biotech Competent Cells Product and Solutions
Table 16. Yeastern Biotech Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Takara Bio Corporate Information, Location and Competitors
Table 18. Takara Bio Competent Cells Major Business
Table 19. Takara Bio Competent Cells Total Revenue (USD Million) (2017-2018)
Table 20. Takara Bio SWOT Analysis
Table 21. Takara Bio Competent Cells Product and Solutions
Table 22. Takara Bio Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 24. Thermo Fisher Scientific Competent Cells Major Business
Table 25. Thermo Fisher Scientific Competent Cells Total Revenue (USD Million) (2017-2018)
Table 26. Thermo Fisher Scientific SWOT Analysis
Table 27. Thermo Fisher Scientific Competent Cells Product and Solutions
Table 28. Thermo Fisher Scientific Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. GeneScript Corporation Corporate Information, Location and Competitors
Table 30. GeneScript Corporation Competent Cells Major Business
Table 31. GeneScript Corporation Competent Cells Total Revenue (USD Million) (2017-2018)
Table 32. GeneScript Corporation SWOT Analysis
Table 33. GeneScript Corporation Competent Cells Product and Solutions
Table 34. GeneScript Corporation Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Agilent Technologies Corporate Information, Location and Competitors
Table 36. Agilent Technologies Competent Cells Major Business
Table 37. Agilent Technologies Competent Cells Total Revenue (USD Million) (2017-2018)
Table 38. Agilent Technologies SWOT Analysis
Table 39. Agilent Technologies Competent Cells Product and Solutions
Table 40. Agilent Technologies Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. QIAGEN N.V. Corporate Information, Location and Competitors
Table 42. QIAGEN N.V. Competent Cells Major Business
Table 43. QIAGEN N.V. Competent Cells Total Revenue (USD Million) (2017-2018)
Table 44. QIAGEN N.V. SWOT Analysis
Table 45. QIAGEN N.V. Competent Cells Product and Solutions
Table 46. QIAGEN N.V. Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Beijing TransGen Biotech Corporate Information, Location and Competitors
Table 48. Beijing TransGen Biotech Competent Cells Major Business
Table 49. Beijing TransGen Biotech Competent Cells Total Revenue (USD Million) (2017-2018)
Table 50. Beijing TransGen Biotech SWOT Analysis
Table 51. Beijing TransGen Biotech Competent Cells Product and Solutions
Table 52. Beijing TransGen Biotech Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Promega Corporation Corporate Information, Location and Competitors
Table 54. Promega Corporation Competent Cells Major Business
Table 55. Promega Corporation Competent Cells Total Revenue (USD Million) (2017-2018)
Table 56. Promega Corporation SWOT Analysis
Table 57. Promega Corporation Competent Cells Product and Solutions
Table 58. Promega Corporation Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. New England Biolabs Corporate Information, Location and Competitors
Table 60. New England Biolabs Competent Cells Major Business
Table 61. New England Biolabs Competent Cells Total Revenue (USD Million) (2017-2018)
Table 62. New England Biolabs SWOT Analysis
Table 63. New England Biolabs Competent Cells Product and Solutions
Table 64. New England Biolabs Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Bioline Corporate Information, Location and Competitors
Table 66. Bioline Competent Cells Major Business
Table 67. Bioline Competent Cells Total Revenue (USD Million) (2017-2018)
Table 68. Bioline SWOT Analysis
Table 69. Bioline Competent Cells Product and Solutions
Table 70. Bioline Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Cell Applications Corporate Information, Location and Competitors
Table 72. Cell Applications Competent Cells Major Business
Table 73. Cell Applications Competent Cells Total Revenue (USD Million) (2017-2018)
Table 74. Cell Applications SWOT Analysis
Table 75. Cell Applications Competent Cells Product and Solutions
Table 76. Cell Applications Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. OriGene Technologies Corporate Information, Location and Competitors
Table 78. OriGene Technologies Competent Cells Major Business
Table 79. OriGene Technologies Competent Cells Total Revenue (USD Million) (2017-2018)
Table 80. OriGene Technologies SWOT Analysis
Table 81. OriGene Technologies Competent Cells Product and Solutions
Table 82. OriGene Technologies Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Scarab Genomics Corporate Information, Location and Competitors
Table 84. Scarab Genomics Competent Cells Major Business
Table 85. Scarab Genomics Competent Cells Total Revenue (USD Million) (2017-2018)
Table 86. Scarab Genomics SWOT Analysis
Table 87. Scarab Genomics Competent Cells Product and Solutions
Table 88. Scarab Genomics Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Delphi Genetics Corporate Information, Location and Competitors
Table 90. Delphi Genetics Competent Cells Major Business
Table 91. Delphi Genetics Competent Cells Total Revenue (USD Million) (2017-2018)
Table 92. Delphi Genetics SWOT Analysis
Table 93. Delphi Genetics Competent Cells Product and Solutions
Table 94. Delphi Genetics Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Bio-Rad Laboratories Corporate Information, Location and Competitors
Table 96. Bio-Rad Laboratories Competent Cells Major Business
Table 97. Bio-Rad Laboratories Competent Cells Total Revenue (USD Million) (2017-2018)
Table 98. Bio-Rad Laboratories SWOT Analysis
Table 99. Bio-Rad Laboratories Competent Cells Product and Solutions
Table 100. Bio-Rad Laboratories Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Lucigen Corporate Information, Location and Competitors
Table 102. Lucigen Competent Cells Major Business
Table 103. Lucigen Competent Cells Total Revenue (USD Million) (2017-2018)
Table 104. Lucigen SWOT Analysis
Table 105. Lucigen Competent Cells Product and Solutions
Table 106. Lucigen Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. BioDynamics Laboratory Competent Cells Type and Application
Table 108. BioDynamics Laboratory Competent Cells Major Business
Table 109. BioDynamics Laboratory Competent Cells Total Revenue (USD Million) (2017-2018)
Table 110. BioDynamics Laboratory SWOT Analysis
Table 111. BioDynamics Laboratory Competent Cells Product and Solutions
Table 112. BioDynamics Laboratory Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. IBA GmBH Corporate Information, Location and Competitors
Table 114. IBA GmBH Competent Cells Major Business
Table 115. IBA GmBH Competent Cells Total Revenue (USD Million) (2017-2018)
Table 116. IBA GmBH SWOT Analysis
Table 117. IBA GmBH Competent Cells Product and Solutions
Table 118. IBA GmBH Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. Zymo Research Corporate Information, Location and Competitors
Table 120. Zymo Research Competent Cells Major Business
Table 121. Zymo Research Competent Cells Total Revenue (USD Million) (2017-2018)
Table 122. Zymo Research SWOT Analysis
Table 123. Zymo Research Competent Cells Product and Solutions
Table 124. Zymo Research Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. GCC Biotech Corporate Information, Location and Competitors
Table 126. GCC Biotech Competent Cells Major Business
Table 127. GCC Biotech Competent Cells Total Revenue (USD Million) (2017-2018)
Table 128. GCC Biotech SWOT Analysis
Table 129. GCC Biotech Competent Cells Product and Solutions
Table 130. GCC Biotech Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 131. SMOBIO Technology Corporate Information, Location and Competitors
Table 132. SMOBIO Technology Competent Cells Major Business
Table 133. SMOBIO Technology Competent Cells Total Revenue (USD Million) (2017-2018)
Table 134. SMOBIO Technology SWOT Analysis
Table 135. SMOBIO Technology Competent Cells Product and Solutions
Table 136. SMOBIO Technology Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 137. Edge BioSystems Corporate Information, Location and Competitors
Table 138. Edge BioSystems Competent Cells Major Business
Table 139. Edge BioSystems Competent Cells Total Revenue (USD Million) (2017-2018)
Table 140. Edge BioSystems SWOT Analysis
Table 141. Edge BioSystems Competent Cells Product and Solutions
Table 142. Edge BioSystems Competent Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 143. Global Competent Cells Revenue (Million USD) by Players (2015-2020)
Table 144. Global Competent Cells Revenue Share by Players (2015-2020)
Table 145. Global Competent Cells Revenue (Million USD) by Regions (2015-2020)
Table 146. Global Competent Cells Revenue Market Share by Regions (2015-2020)
Table 147. North America Competent Cells Revenue by Countries (2015-2020)
Table 148. North America Competent Cells Revenue Market Share by Countries (2015-2020)
Table 149. Europe Competent Cells Revenue (Million USD) by Countries (2015-2020)
Table 150. Asia-Pacific Competent Cells Revenue (Million USD) by Countries (2015-2020)
Table 151. South America Competent Cells Revenue by Countries (2015-2020)
Table 152. South America Competent Cells Revenue Market Share by Countries (2015-2020)
Table 153. Middle East and Africa Competent Cells Revenue (Million USD) by Countries (2015-2020)
Table 154. Middle East and Africa Competent Cells Revenue Market Share by Countries (2015-2020)
Table 155. Global Competent Cells Revenue (Million USD) by Type (2015-2020)
Table 156. Global Competent Cells Revenue Share by Type (2015-2020)
Table 157. Global Competent Cells Revenue Forecast by Type (2021-2025)
Table 158. Global Competent Cells Revenue by Application (2015-2020)
Table 159. Global Competent Cells Revenue Share by Application (2015-2020)
Table 160. Global Competent Cells Revenue Forecast by Application (2021-2025)
Table 161. Global Competent Cells Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Competent Cells Picture
Figure 2. Global Competent Cells Revenue Market Share by Type in 2019
Figure 3. Chemically Competent Cells Picture
Figure 4. Electrocompetent Cells Picture
Figure 5. Competent Cells Revenue Market Share by Application in 2019
Figure 6. Subcloning & Routine Cloning Picture
Figure 7. Phage Display Library Construction Picture
Figure 8. Toxic/Unstable DNA Cloning Picture
Figure 9. High-Throughput Cloning Picture
Figure 10. Protein Expression Picture
Figure 11. Mutagenesis Picture
Figure 12. Single-Stranded DNA Production Picture
Figure 13. Bacmid creation Picture
Figure 14. Cre-lox recombination (PIR1/PIR2) Picture
Figure 15. Global Competent Cells Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Competent Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Competent Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Competent Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Competent Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Competent Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Competent Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Competent Cells Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Competent Cells Revenue Market Share in 2019
Figure 24. Global Top 10 Players Competent Cells Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Competent Cells Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Competent Cells Revenue Market Share by Regions (2015-2020)
Figure 28. Global Competent Cells Revenue Market Share by Regions in 2018
Figure 29. North America Competent Cells Revenue and Growth Rate (2015-2020)
Figure 30. Europe Competent Cells Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Competent Cells Revenue and Growth Rate (2015-2020)
Figure 32. South America Competent Cells Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Competent Cells Revenue and Growth Rate (2015-2020)
Figure 34. North America Competent Cells Revenue Market Share by Countries (2015-2020)
Figure 35. North America Competent Cells Revenue Market Share by Countries in 2019
Figure 36. USA Competent Cells Revenue and Growth Rate (2015-2020)
Figure 37. Canada Competent Cells Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Competent Cells Revenue and Growth Rate (2015-2020)
Figure 39. Europe Competent Cells Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Competent Cells Revenue Market Share by Countries in 2019
Figure 41. Germany Competent Cells Revenue and Growth Rate (2015-2020)
Figure 42. UK Competent Cells Revenue and Growth Rate (2015-2020)
Figure 43. France Competent Cells Revenue and Growth Rate (2015-2020)
Figure 44. Russia Competent Cells Revenue and Growth Rate (2015-2020)
Figure 45. Italy Competent Cells Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Competent Cells Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Competent Cells Revenue Market Share by Countries in 2019
Figure 48. China Competent Cells Revenue and Growth Rate (2015-2020)
Figure 49. Japan Competent Cells Revenue and Growth Rate (2015-2020)
Figure 50. Korea Competent Cells Revenue and Growth Rate (2015-2020)
Figure 51. India Competent Cells Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Competent Cells Revenue and Growth Rate (2015-2020)
Figure 53. South America Competent Cells Revenue Market Share by Countries (2015-2020)
Figure 54. South America Competent Cells Revenue Market Share by Countries in 2019
Figure 55. Brazil Competent Cells Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Competent Cells Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Competent Cells Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Competent Cells Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Competent Cells Revenue and Growth Rate (2015-2020)
Figure 60. UAE Competent Cells Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Competent Cells Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Competent Cells Revenue and Growth Rate (2015-2020)
Figure 63. Global Competent Cells Revenue Share by Type (2015-2020)
Figure 64. Global Competent Cells Revenue Share by Type in 2019
Figure 65. Global Competent Cells Market Share Forecast by Type (2021-2025)
Figure 66. Global Chemically Competent Cells Revenue Growth Rate (2015-2020)
Figure 67. Global Electrocompetent Cells Revenue Growth Rate (2015-2020)
Figure 68. Global Competent Cells Revenue Share by Application (2015-2020)
Figure 69. Global Competent Cells Revenue Share by Application in 2019
Figure 70. Global Competent Cells Market Share Forecast by Application (2021-2025)
Figure 71. Global Subcloning & Routine Cloning Revenue Growth Rate (2015-2020)
Figure 72. Global Phage Display Library Construction Revenue Growth Rate (2015-2020)
Figure 73. Global Toxic/Unstable DNA Cloning Revenue Growth Rate (2015-2020)
Figure 74. Global High-Throughput Cloning Revenue Growth Rate (2015-2020)
Figure 75. Global Protein Expression Revenue Growth Rate (2015-2020)
Figure 76. Global Mutagenesis Revenue Growth Rate (2015-2020)
Figure 77. Global Single-Stranded DNA Production Revenue Growth Rate (2015-2020)
Figure 78. Global Bacmid creation Revenue Growth Rate (2015-2020)
Figure 79. Global Cre-lox recombination (PIR1/PIR2) Revenue Growth Rate (2015-2020)
Figure 80. Global Competent Cells Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Competent Cells Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Competent Cells Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Competent Cells Revenue Market Forecast (2021-2025)
Figure 84. Europe Competent Cells Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Competent Cells Revenue Market Forecast (2021-2025)
Figure 86. South America Competent Cells Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Competent Cells Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets